A bcl-xS adenovirus selectively induces apoptosis in transformed cells compared to normal mammary cells

Neoplasia

Volumn 2, Issue 3, 2000, Pages 251-260

  Sumantran, Venil N ^a   Lee, David S ^a   Woods Ignatoski, Kathleen M ^a   Ethier, Stephen P ^a   Wicha, Max S ^a,b  

^a UNIVERSITY OF MICHIGAN COMPREHENSIVE CANCER CENTER   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Apoptosis; bcl xS; c erbB 2; Mammary cells; Normal

Indexed keywords

ONCOPROTEIN; PROTEIN BCL 2;

ANIMAL CELL; APOPTOSIS; ARTICLE; BREAST CANCER; BREAST CELL; CANCER CELL; CELL TRANSFORMATION; CELL VIABILITY; CONTROLLED STUDY; HUMAN; MOUSE; NONHUMAN; ONCOGENE; PRIORITY JOURNAL;

EID: 0034129656     PISSN: 15228002     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.neo.7900084     Document Type: Article

References (25)

1. Krajewski S, Krajewska M, Shabaik A, Wang H, Irie S, Fong L, and Reed JC (1994). Immunohistochemical analysis of in vivo patterns of Bcl-x expression. Cancer Res 54, 5501-5507.
2. Olufunmilayo I, Olopade MO, Adenyaju SAR, Hagos M, Mick R, and Thompson CB (1997). Overexpression of Bcl-X in primary breast cancer is associated with high tumor grade and metastases. The Cancer Journal from Scientific American 3, 230-237.
3. Boise LH, Gonzalez-Garcia M, Postema CE, Ding L, Lindsten T, Turka LA, Mao X, Nunez G, and Thompson CB (1993). bcl-x, a bcl-2 related gene that functions as a dominant regulator of apoptotic cell death. Cell 74, 597-608.
4. Sumantran VN, Ealovega MW, Nunez G, Clarke MF, and Wicha MS (1995). Overexpression of Bcl-xS sensitizes MCF-7 cells to chemotherapy induced apoptosis. Cancer Res 55, 2507-2510.
5. Ealovega MW, McGinnis PK, Sumantran VN, Clarke MF, and Wicha MS (1996). bcl-xS gene therapy induces apoptosis of human mammary tumors in Nude mice. Cancer Res 56, 1965-1969.
6. Evan GI, Wyllie AH, Gilbert CS, Land H, Brooks M, Waters CM, Penn LZ, and Hancock DC (1992). Induction of apoptosis in fibroblasts by c-myc protein. Cell 69, 119-128.
7. Thompson EB (1998). The many roles of c-myc in apoptosis. Adv Pharmacol 41, 575-600.
8. Berns PM, Klijn JG, Look MP, Staveren IL, Peters HA, Portengen H, and Foekens JA (1996). Evaluation of markers for metastasis and oncogene amplification as prognostic factors in 496 primary breast cancer patients (Meetings Abstract). Breast Cancer Res Treat 37, 34.
9. Slamon DJ, Clark GM, Wong SG, Levin WJ, Ulrich A, and McGuire WL (1987). Human breast cancer: correlation of relapse and survival with amplification of the Her-2/neu oncogene. Science 235, 177-182.
10. Berger MS, Locher GW, Saurer S, Gullick WJ, Waterfield MD, Groner B, and Hynes NE (1988). Correlation of c-erbB-2 gene amplification and protein expression in human breast carcinoma with nodal status and nuclear grading. Cancer Res 48, 1238-1243.
11. Amundadottir LT, Nass SJ, Berchem GJ, Johnson MD, and Dickson RB (1996). Cooperation of TGF-α and c-myc in mouse mammary tumorigenesis: coordinated stimulation of growth and suppression of apoptosis. Oncogene 13, 757-765.
12. Danielson KG, Knepper JE, Kittrell FS, Butel JS, Medina D, and Durban EM (1989). Clonal populations of the mouse mammary cell line Comma-1D which retain ability of morphogenesis in vivo. In Vitro Cell Dev Biol 25, 535-543.
13. Band V, Zhajchowski D, Swisshelm D, Trask DK, Kulesa V, Cohen C, Connolly J, and Sager R. (1990). Tumor progression in four mammary epithelial cell lines derived from the same patient. Cancer Res 50, 7351-7357.
14. Harris KF, Christensen JB, Radany EH, and Imperiale MJ (1998). Novel mechanisms of E2F induction by BK virus large T antigen: requirement of both pRb binding and J domains. Mol Cell Biol 18, 1746-1756.
15. Ignatoski KMW, LaPointe AJ, Radany EH, and Ethier SP (1999). erbB2 overexpression in human mammary epithelial cells confers growth factor Independence. Endocrinology 140, 3615-3622.
16. Clarke MF Apel, IF, Benedict MA, Eipers PG, Sumantran VN, Gonzalez-Garcia M, Doedens M, Fukunaga N, Davidson B, Dick JE, Minn AJ, Boise LH, Thompson CB, Wicha MS, and NunezG (1995). A recombinant bcl-xS adenovirus selectively induces apoptosis in cancer cells but not in normal bone marrow cells. Proc Natl Acad Sci USA 92, 11024-11028.
17. Stratford-Pericaudet LD, Makeh I, Perricaudet M, and Briand P (1992). Widespread long-term gene transfer to mouse skeletal muscles and heart. J Clin Invest 90, 626-630.
18. Arakawa H, Maeda M, and Tsuji A (1991). Chemiluminescent assay of various enzymes using indoxyl derivatives as substrate and its applications to enzyme immunoassay and DNA probe assay. Anal Biochem 199, 238-242.
19. Kao CY, Nomata K, Oakley CS, Welsch CW, and Chang CC (1995). Two types of normal human breast epithelial cells derived from reduction mammoplasty: phenotypic characterization and response to SV40 transfection. Carcinogenesis 16, 531-538.
20. Ignatoski KMW, and Ethier SPE (1999). Constitutive activation of pp125 fak in newly isolated human breast cancer cell lines. Breast Cancer Res Treat 54, 173-182.
21. Serra R, Pelton RW, and Moses HL (1994). TGF-β 1 inhibits branching morphogenesis and N-myc expression in lung bud organ cultures. Development 120, 2153-2161.
22. Ignatoski KMW, Maehama T, Markwart SM, Dixon JE, Livant DL, and Ethier SP (in press). erbB2 overexpression confers Pl-3′ kinase dependent invasion capacity on Human Mammary Epithelial cells. Br J Cancer. In press.
23. Reed JC (1997). Bcl-2 family proteins: strategies for overcoming chemoresistance in cancer. 1998. Adv Pharmacol 41, 501-532.
24. Evan GI, Brown L, Whyte M, and Harrington E (1995). Apoptosis and the cell cycle. Curr Opin Cell Biol 7, 825-834.
25. Pegram MD, Finn RS, Arzoo K, Beryt M, Pietras RJ, and Slamon DJ (1997). The effect of Her-2/neu overexpression on the chemotherapeutic drug sensitivity in human breast and ovarian cancer cells. Oncogene 15, 537-547.